Cardiac MRI in infiltrative disorders: A concise review

Current Cardiology Reviews

Volumn 6, Issue 2, 2010, Pages 134-136

  Penugonda, Neelima ^a  

^a LANKENAU HOSPITAL   (United States)

Author keywords

Amyloidosis; Cardiac MRI; Hemochromatosis; Infiltrative disorders; Sarcoidosis

Indexed keywords

AMYLOIDOSIS; CARDIOVASCULAR DISEASE; HEART; HEMOCHROMATOSIS; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SARCOIDOSIS;

EID: 77951604603     PISSN: 1573403X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340310791162668     Document Type: Review

References (15)

1. JD T-T. Heart involvement in lymphomas. The value of magnetic resonance imaging and two-dimensional echocardiography at disease presentation. Cancer 1993; 72(8): 2484-90.
2. Herbert FM, Sebastian G. Magnetic resonance imaging evaluation of myocardial and pericardial disease. J Magn Reson 1999: 10(5): 617-26.
3. Jensen PD. Heart transplantation in a case of juvenile hereditary haemochromatosis followed up by MRI and endomyocardial biopsies. Eur J Haematol 1993; 51(4): 199-205.
4. Blankenberg F, Eisenberg S, Scheinman MN, Higgins CB. Use of cine gradient echo (GRE) MR in the imaging of cardiac hemochromatosis. J Comput Assist Tomogr 1994; 18(1): 136-8.
5. Ptaszek LM. Early diagnosis of hemochromatosis-related cardiomyopathy with magnetic resonance imaging. J Cardiovasc Magn Reson 2005; 7(4): 689-92.
6. Benjamin CM, Steffen H, Raja M, Scott DF. Evaluation of myocardial iron overload by T2* cardiovascular magnetic resonance imaging. Tex Heart Inst J 2005; 32(3): 448-9.
7. Sueyoshi E, Sakamoto I, Okimoto T, Hayashi K, Tanaka K, Toda G. Cardiac amyloidosis: typical imaging findings and diffuse myocardial damage demonstrated by delayed contrast-enhanced MRI. Cardiovasc Intervent Radiol 2006; 29(4): 710-2.
8. Adrian SH, Cheng APB. Cardiac changes in systemic amyloidosis: Visualisation by magnetic resonance imaging. Int J Cardiol 2006; 133(1): E21-E23.
9. Krombach GA, Hahn C, Tomars M, et al. Cardiac amyloidosis: MR imaging findings and T1 quantification, comparison with control subjects. J Magn Reson Imaging 2007; 25(6): 1283-7.
10. Bargout R, Kelly RF. Sarcoid heart disease: clinical course and treatment. Int J Cardiol 2004; 97(2): 173-82.
11. Furushima MC, Sugiura H, Kasai H, Washizuka T, Aizawa Y. Ventricular tachyarrhythmia associated with cardiac sarcoidosis: its mechanisms and outcome. Clin Cardiol 2004; 27(4): 217-22.
12. Osman AF, Leyva P, Pitt M, Murray R. Early diagnosis of cardiac sarcoidosis using magnetic resonance imaging. Int J Cardiol 2008; 125(1): e4-e5.
13. Sparrow PJ, Kurian JB, Jones TR, Sivananthan MU. MR imaging of cardiac tumors. Radiographics 2005; 25(5): 1255-76.
14. Castillo E, Bluemke DA. Cardiac MR imaging. Radiol Clin North Am 2003; 41(1): 17-28.
15. Joseph B, Selvanayagam PNH, Biju P, Saul G. Myerson and Stefan Neubauer Evaluation and management of the cardiac amyloidosis. J Am Coll Cardiol 2007; 50(22): 2101-10.